知镜 Cognispect · 医学文献与研究工作台

Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina.

Cayol F, Macharashvili I, Barochiner J, Dominguez MP, Menna E, Perez Mesa PJ, Pandolfi J, Carranza O, Sanchez R, Marchioni A, Gueron G, Pena L, Cerini M, Cutuli H, Rivello HG, Taetti G, Camacho AF.
JCO global oncology · 2026-08-27 · PMID 42659586

文献摘要

Purpose The genomic landscape of advanced urothelial carcinoma (aUC) has enabled the development of targeted therapies; however, real-world data from Latin America remain limited. Materials and methods We conducted a multicenter retrospective study including patients with aUC who underwent next-generation sequencing on tumor tissue. Molecular alterations were classified according to the European Society for Medical Oncology (ESMO) Scale for Clinical Actionability of Molecular Targets (ESCAT). Results A total of 107 patients were included. Overall, 68 patients (63.6%) harbored at least one potentially actionable molecular alteration. Among these, 34 patients (31.8%) exhibited ESCAT level I alterations, most commonly involving FGFR3 mutations/fusions and ERBB2 amplification. Conclusion A clinically meaningful proportion of Argentine patients with aUC harbor ESCAT level I actionable alterations, supporting the incorporation of routine genomic profiling into clinical practice.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。